| Sep'19 | Sep'18 | Sep'17 | Sep'16 | Sep'15 | Sep'14 | Sep'13 | Sep'12 | Sep'11 | Sep'10 |
|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | |||||||||
Net loss | |||||||||
-8,632 | -11,692 | - | - | - | - | - | - | - | - |
Net loss | |||||||||
- | - | -12,855 | -12,175 | -11,881 | -13,066 | -17,686 | -7,150 | -10,515 | -7,909 |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||
Depreciation and amortization | |||||||||
390 | 547 | 633 | 706 | 490 | 442 | 206 | 313 | 367 | 371 |
Loss on extinguishment of debt | |||||||||
-1,260 | 0 | - | - | - | - | - | - | - | - |
Unrealized gain on change in fair value of senior secured convertible notes | |||||||||
1,972 | 0 | - | - | - | - | - | - | - | - |
Impairment expense | |||||||||
- | - | 253 | - | - | - | - | - | - | - |
Impairment of intellectual property | |||||||||
- | - | - | - | - | - | 114 | - | - | - |
Stock-based compensation | |||||||||
1,129 | 1,356 | 3,257 | 2,038 | 4,022 | 2,033 | 1,517 | 1,953 | 1,444 | 1,250 |
Non-cash in process research and development | |||||||||
251 | 0 | - | - | - | - | - | - | - | - |
Fair value of vested options issued to officers, directors and employees | |||||||||
- | - | - | - | - | - | - | - | 1,485 | - |
Change in fair value of warrant liability | |||||||||
- | - | - | - | 2,994 | - | 7,508 | - | - | - |
Loss on sale of property and equipment | |||||||||
- | - | - | -5 | - | - | - | - | - | - |
Loss on conversion of promissory notes | |||||||||
- | - | - | - | 980 | - | - | - | - | - |
Change in fair value of warrant liability | |||||||||
- | - | - | - | - | 908 | - | - | - | - |
Common stock issued for consulting services | |||||||||
- | - | - | 78 | 136 | 337 | - | - | - | - |
Security deposit write-off | |||||||||
- | - | - | 10 | - | - | - | - | - | - |
Fair value of vested options issued to officers, directors and employees | |||||||||
- | - | - | - | - | - | - | - | - | 2,545 |
Amortization of debt issuance costs | |||||||||
23 | 1 | - | - | - | - | - | 85 | 858 | 331 |
Amortization of debt discount attributable to convertible debentures | |||||||||
- | - | - | - | - | - | - | 541 | 2,096 | 512 |
Fair value of vested warrants issued for service | |||||||||
- | - | - | - | - | - | -28 | -58 | - | - |
Common stock issued in settlement of interest | |||||||||
- | - | - | - | - | - | - | 102 | 36 | 195 |
Fair value change from employee option modifications | |||||||||
- | - | - | - | - | - | -408 | - | 738 | - |
Provision for bad debts | |||||||||
7 | 20 | 423 | 116 | 34 | 19 | 77 | - | - | - |
Change in operating assets and liabilities: | |||||||||
Accounts receivable | |||||||||
-638 | -1,081 | -3,084 | 2,597 | 4,635 | 181 | 453 | 88 | 145 | 15 |
Inventories | |||||||||
-78 | -105 | 28 | -16 | -30 | - | - | - | - | - |
Prepaid expenses and other current assets and deposits | |||||||||
-23 | 268 | 167 | 297 | 78 | -32 | 109 | 16 | -70 | -31 |
Accounts payable and accrued liabilities | |||||||||
667 | 426 | -610 | -253 | 1,241 | 527 | 517 | 239 | -199 | 230 |
Deferred revenue | |||||||||
-727 | 1,504 | - | - | - | - | - | - | - | - |
Deferred revenue | |||||||||
- | - | -1,469 | 2,455 | -301 | 434 | - | - | - | - |
Proceeds from sale of Series A preferred stock | |||||||||
- | - | - | - | - | - | 10,735 | - | - | - |
Proceeds from exercise of warrants | |||||||||
- | - | - | 4 | - | - | - | - | - | - |
Net cash used in operating activities | |||||||||
-6,861 | -6,917 | -7,479 | - | - | - | - | - | - | - |
Cash flows from investing activities: | |||||||||
Purchase of property and equipment | |||||||||
67 | 266 | 145 | 672 | 351 | 229 | 636 | 162 | 89 | - |
Net cash used in operating activities | |||||||||
- | - | - | -9,896 | -6,965 | -8,512 | -7,870 | -3,960 | -3,761 | -2,455 |
Proceeds from sale of property and equipment | |||||||||
- | - | - | 5 | - | - | - | - | - | - |
Purchase of assets under asset purchase agreement | |||||||||
- | - | - | - | 1,500 | - | 584 | - | - | - |
Purchase of intangible asset | |||||||||
- | - | - | 112 | 286 | - | - | - | - | - |
Net cash used in investing activities | |||||||||
-67 | -266 | -145 | - | - | - | - | - | - | - |
Cash flows from financing activities: | |||||||||
Net proceeds from private placement | |||||||||
402 | 0 | - | - | - | - | - | - | - | - |
Net proceeds from exercise of warrants | |||||||||
987 | 0 | - | - | - | - | - | - | - | - |
Net cash used in investing activities | |||||||||
- | - | - | -779 | -2,138 | -229 | -1,220 | -162 | -89 | - |
Net proceeds from sale of common stock and warrants | |||||||||
2,463 | 4,233 | 6,105 | 7,853 | 19,114 | - | - | - | - | - |
Repayment of convertible notes | |||||||||
1,985 | 1,650 | - | - | - | - | - | - | - | - |
Capitalized offering costs | |||||||||
-10 | 0 | - | - | - | - | - | - | - | - |
Net proceeds from (payments of) related party advances | |||||||||
- | - | - | - | - | - | - | - | -50 | 50 |
Net proceeds from sale of common stock and warrants | |||||||||
- | - | - | - | - | 2,156 | 3,900 | 2,101 | 4,735 | - |
Proceeds from promissory notes, including $1,000,000 from a related party | |||||||||
- | - | - | - | - | 1,800 | - | - | - | - |
Deferred offering costs | |||||||||
- | - | - | 13 | - | 181 | - | - | - | - |
Purchase and cancellation of previously issued warrants | |||||||||
- | - | - | 0 | 4,090 | - | 60 | - | - | - |
Proceeds from exercise of options and warrants | |||||||||
- | - | - | - | - | - | 151 | - | - | - |
Net proceeds from issuance of convertible notes | |||||||||
- | - | - | - | - | - | - | - | 1,895 | 2,209 |
Net cash provided by financing activities | |||||||||
- | - | - | 7,843 | 15,023 | 3,775 | 14,726 | 2,101 | 6,580 | 2,259 |
Net cash provided by financing activities | |||||||||
5,828 | 5,883 | 6,105 | - | - | - | - | - | - | - |
Net increase (decrease) in cash and cash equivalents | |||||||||
-1,100 | -1,300 | - | - | - | - | - | - | - | - |
Net decrease in cash and cash equivalents | |||||||||
- | - | -1,519 | -2,832 | 5,919 | -4,967 | 5,635 | -2,022 | 2,729 | -195 |
Supplemental Disclosures of Cash Flow Information: | |||||||||
Cash paid during period for interest | |||||||||
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash paid during period for income taxes | |||||||||
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Non-cash investing and financing activities: | |||||||||
Impact of adoption of new accounting pronouncements included in accumulated deficit | |||||||||
493 | 0 | - | - | - | - | - | - | - | - |
Interest paid in kind (related party of $35,550 for the six month period ended March 31, 2019) | |||||||||
126 | 0 | - | - | - | - | - | - | - | - |
Offering costs incurred, and included in accounts payable | |||||||||
99 | 64 | - | - | - | - | - | - | - | - |
Warrants exercised cashlessly | |||||||||
0 | 0 | - | - | - | - | - | - | - | - |
Conversion of notes payable | |||||||||
1,440 | 0 | - | - | - | - | - | - | - | - |
Deemed dividend-warrant repricing | |||||||||
309 | 0 | - | - | - | - | - | - | - | - |
Reclassification of warrants from liability to equity upon exercise of warrants | |||||||||
- | - | - | - | - | 2,455 | - | - | - | - |
Common stock and warrants issued upon conversion of promissory notes payable and accrued interest | |||||||||
- | - | - | - | 1,843 | - | - | 4,687 | 373 | 3,031 |
Fair value of warrants issued for financing costs | |||||||||
- | - | - | - | - | - | 0 | 0 | 217 | - |
Property and equipment acquired, and included in accounts payable | |||||||||
- | - | - | 10 | 1 | - | 6 | - | - | - |
Intangible assets acquired, and included in accounts payable | |||||||||
- | - | - | - | 11 | - | - | - | - | - |
Common stock issued upon conversion of Series A and Series B preferred stock | |||||||||
- | - | - | - | - | - | 67 | - | - | - |
Common stock issued for cashless exercise of options | |||||||||
- | - | - | 0 | 0 | 0 | 49 | - | - | - |
Deferred offering costs reclassified to additional paid in capital | |||||||||
- | - | 13 | - | 181 | - | - | - | - | - |